A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Verastem, Inc.
Verastem, Inc.
Boehringer Ingelheim
Replimune Inc.
AstraZeneca
Carevive Systems, Inc.
DualityBio Inc.
Lumicell, Inc.
Hoffmann-La Roche
Varian, a Siemens Healthineers Company
I-Mab Biopharma US Limited
Shanghai Juncell Therapeutics
BicycleTx Limited
Revolution Medicines, Inc.
Bolt Biotherapeutics, Inc.
Revolution Medicines, Inc.
Second Life Therapeutics
Turning Point Therapeutics, Inc.
Marengo Therapeutics, Inc.
Hoffmann-La Roche
Tempus AI
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Celldex Therapeutics
Hoffmann-La Roche
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Silverback Therapeutics
Mirror Biologics, Inc.
Auron Healthcare GmbH
Poniard Pharmaceuticals
Poniard Pharmaceuticals
Pharmacyclics LLC.
FeRx